Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Single Cell Transcriptomics Revealed AML and Non-AML Cell Clusters Relevant to Relapse and Remission in Pediatric AML

Beena E Thomas, Pruthvi Perumalla, MS, Swati S Bhasin, PhD, Debasree Sarkar, PhD, Bhakti Dwivedi, PhD, Sunita I Park, MD, Deborah DeRyckere, BS,PhD, Curtis J. Henry, PhD, Sunil S. Raikar, MD, Christopher C. Porter, MD, Melinda Pauly, MD, Ryan J Summers, MD, Sharon M. Castellino, MD MSc, Daniel S. Wechsler, MD PhD, Douglas K Graham, MD PhD, Manoj Bhasin, PhD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-142513

Published: 2020

Journal Articles

Brentuximab Vedotin Plus Bendamustine for Pediatric Patients with Relapsed/Refractory Hodgkin Lymphoma: A Multi-Institution Retrospective Analysis

Christopher J. Forlenza, MD, Nitya Gulati, MBBS, Audrey Mauguen, PhD, Michael J. Absalon, Sharon M. Castellino, MD MSc, Anna Franklin, MD, Frank G. Keller, MD, Neal Shukla, MD

Blood (2020) 136 (Supplement 1): 35.

https://doi.org/10.1182/blood-2020-139480

Published: 2020

Journal Articles

Increased Tumor Specific Cytotoxic T Cell Responses and Reversion to a Favorable Cytokine Profile after Treatment in Patients with Newly Diagnosed High Risk Hodgkin Lymphoma Treated on Children's Oncology Group Trial-AHOD1331

Hema Dave, Mimi Mai, Anushree Datar, Gaye Jenkins, BS, Qinglin Pei, PhD, Yue Wu, MS, Frank G. Keller, MD, Sharon M. Castellino, MD MSc, Terzah M Horton, MD PhD, Catherine M. Bollard, MD MBChB

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-136376

Published: 2020

Journal Articles

Premedication and Longer Infusion Time Do Not Reduce the Incidence of Hypersensitivity Reactions to Pegaspargase

Catherine Hughes, PharmD, Valeria Bernardo, PharmD, Susanne Youssef, PharmD, James P. Hughes, PhD, Frank G. Keller, MD, Tamara P. Miller, MDMSc, Sharon M. Castellino, MD MSc, Glen Lew, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-143248

Published: 2020

Journal Articles

Characterization of T-ALL-Specific Heterogenous Blast Populations Using High Resolution Single Cell Profiling

Swati S Bhasin, PhD, Ryan J Summers, MD, Beena E Thomas, Debasree Sarkar, PhD, Bhakti Dwivedi, PhD, Sunita I Park, MD, Deborah DeRyckere, BS,PhD, Sharon M. Castellino, MD MSc, Manoj Bhasin, PhD, Douglas K Graham, MD PhD

Blood (2020) 136 (Supplement 1): 11–12.

https://doi.org/10.1182/blood-2020-143017

Published: 2020

Journal Articles

Survival Varies By Age and Histology in Classical Hodgkin Lymphoma: A Report from the Children's Oncology Group

Justine M. Kahn, MDMSc, Kara M. Kelly, MD, Qinglin Pei, PhD, Yue Wu, MS, Debra L. Friedman, MD, Tara O. Henderson, MD MPH, David C. Hodgson, MD MPH, FRCPC, Joel A. Kaplan, DO, MPH, Frank G. Keller, MD, Smita Bhatia, MDMPH, Cindy L. Schwartz, MD, Sharon M. Castellino, MD MSc

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-138796

Published: 2020

Journal Articles

Frequency and Timing of Palliative Opportunities in Pediatric Patients with Hematologic Malignancies

Emily J. Labudde, Nicholas P. DeGroote, MPH, Susie Smith, RN, Jonathan Ebelhar, MD, Sharon M. Castellino, MD MSc, Karen Wasilewski-Masker, MD MSc, Katharine E. Brock, MD

Blood (2020) 136 (Supplement 1): 25.

https://doi.org/10.1182/blood-2020-138461

Published: 2020

Journal Articles

Infectious Outcomes of Pediatric Acute Lymphoblastic Leukemia Patients Presenting with Non-Neutropenic Fever

Pratik A. Patel, MD, Nicholas P. DeGroote, MPH, Adam J. Esbenshade, MD MSc, William T. Cash, MDMSc, Sharon M. Castellino, MD MSc, Preeti Jaggi, MD, Tamara P. Miller, MDMSc

Blood (2020) 136 (Supplement 1): 33–34.

https://doi.org/10.1182/blood-2020-139421

Published: 2020

Journal Articles

Evaluation of Activation of a NCI National Clinical Trials Network (NCTN) Study S1826 for Hodgkin Lymphoma (HL) at Children's Oncology Group (COG) Institutions

Sharon M. Castellino, MD MSc, Angela Punnett, MD, Susan K Parsons, MD MRP, Nicholas P. DeGroote, MPH, Sally Muehle, Hongli Li, MS, Michael E. Roth, MD, Alex F. Herrera, MD, Jonathan W. Friedberg, MD MSSc, Nita L. Seibel, MD, Kara M. Kelly, MD

Blood (2020) 136 (Supplement 1): 20.

https://doi.org/10.1182/blood-2020-134738

Published: 2020

Journal Articles

SWOG S1826: A Phase III, Randomized Study of Nivolumab Plus AVD or Brentuximab Vedotin Plus AVD in Patients with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-136422

Published: 2020

Journal Articles

Adverse Events during Induction Therapy in Pediatric Acute Lymphoblastic Lymphoma (ALL)

Zachary West, BS, Kristen Allen, MPH, Caitlin Monroe, MPH, Sharon M. Castellino, MD MSc, Tamara P. Miller, MDMSc

Blood (2019) 134 (Supplement_1): 5809.

https://doi.org/10.1182/blood-2019-131873

Published: 2019

Journal Articles

Productivity Loss Among Parent Caregivers Is Associated with Poor Health-Related Quality of Life (HRQL) at the Intial Diagnosis of Pediatric Advanced Stage Hodgkin Lymphoma (HL)

Susan K Parsons, MD MRP, Sharon M. Castellino, MD MSc, Angie Mae Rodday, PhD, Frank G Keller, MD, Kara M. Kelly, MD, Rena M Conti, PhD, Debra Lerner, PhD MSc, Tara O. Henderson, MDMPH

Blood (2018) 132 (Supplement 1): 975.

https://doi.org/10.1182/blood-2018-99-117316

Published: 2018

Journal Articles

Health-Related Quality of Life (HRQL) Trajectories during Treatment for Advanced Stage Pediatric Hodgkin Lymphoma (HL)

Susan K Parsons, MD MRP, Angie Mae Rodday, PhD MS, Rizvan Bush, MS, Qinglin Pei, PhD, Anem Waheed, MD MPH, Frank G Keller, MD, Kara M. Kelly, MD, Tara O. Henderson, MD MPH, Sharon M. Castellino, MD MSc

Blood (2018) 132 (Supplement 1): 3587.

https://doi.org/10.1182/blood-2018-99-112664

Published: 2018

Journal Articles

Survival By Race/Ethnicity in Children and Adolescents with Hodgkin Lymphoma Treated on Cooperative Group Trials in the U.S. and Canada: A Pooled Analysis of Children's Oncology Group Trials

Justine M. Kahn, MD, Kara M. Kelly, MD, Qinglin Pei, PhD, Debra L. Friedman, MD, Frank Keller, MD, Rizvan Bush, MS, Smita Bhatia, MDMPH, Tara O. Henderson, MD MPH, Cindy L. Schwartz, MD, Sharon M. Castellino, MD MSc

Blood (2017) 130 (Supplement 1): 607.

https://doi.org/10.1182/blood.V130.Suppl_1.607.607

Published: 2017

Journal Articles

Absence of Silent Inactivation Using Intravenous Pegaspargase in Pediatric Acute Lymphoblastic Leukemia

Sarayu Kumar, BA, BSPH, Curtis D Travers, MPH, John Bergsagel, MD, Frank G Keller, MD, Melinda Pauly, MD, Himalee Sabnis, MDMS, Sharon M. Castellino, MD MSc, Glen Lew, MD

Blood (2017) 130 (Supplement 1): 100.

https://doi.org/10.1182/blood.V130.Suppl_1.100.100

Published: 2017

Journal Articles

Outcomes within Five Years from Diagnosis in Pediatric Hodgkin Lymphoma Patients Following Contemporary Therapy

Karen E Effinger, MD MS, John Bergsagel, MD, Taylor Lawrence, Frank G Keller, MD, Rebecca Williamson Lewis, MPH, Lillian Meacham, MD, Ann Mertens, PhD, Sharon M. Castellino, MD MSc

Blood (2017) 130 (Supplement 1): 3466.

https://doi.org/10.1182/blood.V130.Suppl_1.3466.3466

Published: 2017

Journal Articles

Growth Disturbances in Pediatric Patients Receiving Long-Term Tyrosine Kinase Inhibitor Therapy

Himalee Sabnis, MDMS, Caroline Keenum, MD, Rebecca Williamson Lewis, MPH, Emily A. Silverman, Briana Patterson, MD, Karen E. Effinger, MD, John Bergsagel, MD, Ann Mertens, PhD, Sharon M. Castellino, MD MSc

Blood (2017) 130 (Supplement 1): 3425.

https://doi.org/10.1182/blood.V130.Suppl_1.3425.3425

Published: 2017

Journal Articles

Incidence and Predictors of Adverse Respiratory Events during Induction Therapy in Children with Acute Myeloid Leukemia

Lane Miller, MD, Sharon M. Castellino, MD MSc, Ann Mertens, PhD, Frank G Keller, MD, William G Woods, MD

Blood (2017) 130 (Supplement 1): 2590.

https://doi.org/10.1182/blood.V130.Suppl_1.2590.2590

Published: 2017

NARROW

Single Cell Transcriptomics Revealed AML and Non-AML Cell Clusters Relevant to Relapse and Remission in Pediatric AML

Brentuximab Vedotin Plus Bendamustine for Pediatric Patients with Relapsed/Refractory Hodgkin Lymphoma: A Multi-Institution Retrospective Analysis

Increased Tumor Specific Cytotoxic T Cell Responses and Reversion to a Favorable Cytokine Profile after Treatment in Patients with Newly Diagnosed High Risk Hodgkin Lymphoma Treated on Children's Oncology Group Trial-AHOD1331

Premedication and Longer Infusion Time Do Not Reduce the Incidence of Hypersensitivity Reactions to Pegaspargase

Characterization of T-ALL-Specific Heterogenous Blast Populations Using High Resolution Single Cell Profiling

Survival Varies By Age and Histology in Classical Hodgkin Lymphoma: A Report from the Children's Oncology Group

Frequency and Timing of Palliative Opportunities in Pediatric Patients with Hematologic Malignancies

Infectious Outcomes of Pediatric Acute Lymphoblastic Leukemia Patients Presenting with Non-Neutropenic Fever

Evaluation of Activation of a NCI National Clinical Trials Network (NCTN) Study S1826 for Hodgkin Lymphoma (HL) at Children's Oncology Group (COG) Institutions

SWOG S1826: A Phase III, Randomized Study of Nivolumab Plus AVD or Brentuximab Vedotin Plus AVD in Patients with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma

Adverse Events during Induction Therapy in Pediatric Acute Lymphoblastic Lymphoma (ALL)

Productivity Loss Among Parent Caregivers Is Associated with Poor Health-Related Quality of Life (HRQL) at the Intial Diagnosis of Pediatric Advanced Stage Hodgkin Lymphoma (HL)

Health-Related Quality of Life (HRQL) Trajectories during Treatment for Advanced Stage Pediatric Hodgkin Lymphoma (HL)

Survival By Race/Ethnicity in Children and Adolescents with Hodgkin Lymphoma Treated on Cooperative Group Trials in the U.S. and Canada: A Pooled Analysis of Children's Oncology Group Trials

Absence of Silent Inactivation Using Intravenous Pegaspargase in Pediatric Acute Lymphoblastic Leukemia

Outcomes within Five Years from Diagnosis in Pediatric Hodgkin Lymphoma Patients Following Contemporary Therapy

Growth Disturbances in Pediatric Patients Receiving Long-Term Tyrosine Kinase Inhibitor Therapy

Incidence and Predictors of Adverse Respiratory Events during Induction Therapy in Children with Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only